There are currently no clearly defined parameters available for therapy management, as the updated S3 guideline on the diagnosis and treatment of Crohn’s disease published last year states. This is a dilemma that raises the question of other indicators for evaluating the course of treatment. In the PROFILE study, a treatment strategy involving the early use of a biologic proved to be superior to the standard procedure in terms of steroid-free and surgery-free remission.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Rehospitalization risk for cardiopulmonary diseases
Transition to the outpatient setting is crucial
- Telemonitoring
Home earlier: sensory T-shirt monitors vital functions
- Ginkgo biloba for mild dementia: new meta-analysis
Improvements in several domains relevant to everyday life
- From symptom to diagnosis
Dyspnea – Lung metastases
- Potential biomarkers for diagnostics, prognosis and therapy
Male infertility
- Artesunate in uro-oncology
Integrin modulation for the control of metastases in cisplatin-resistant bladder cancer
- Long-term study with dementia patients
Ginkgo biloba extract significantly reduces the risk of progression
- Intestinal microbiome